Abpro Corporation ABP
0.52 USD 0.00 (+0.00%)
At closeMar 9, 2026, 4:00 PM EDT
0.522 Day range 0.759
52-week range unavailable
- YTD
- -87.66%
- 1 year
- -92.43%
News
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket 
defenseworld.net Short Interest in Abpro Holdings Inc. (NASDAQ:ABP) Increases By 271.4% Abpro Holdings Inc. (NASDAQ: ABP - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Gold Moves Lower; CVS Health Earnings Top Views - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Dow Surges Over 200 Points; Coca-Cola Posts Mixed Q4 Results 
benzinga.com Market-Moving News for February 10th SPOT: 16% | Spotify Technology shares are trading higher after reporting better-than-expected Q4 financial results and strong Q1 MAU outlook. ABP: 19% | Abpro Holdings shares are trading- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
globenewswire.com Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid tumors,…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
globenewswire.com Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 FDA clearance enables initiation of Abpro's first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro's global collaboration with…
defenseworld.net Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy? Shares of Abpro Holdings Inc. (NASDAQ: ABP - Get Free Report) were up 0.2% during trading on Thursday. The stock traded as high as $4.80 and last traded at $4.79. Approximately 12,770 shares changed…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
globenewswire.com Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers IND submitted for ABP-102/CT-P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable safety profile ABP-102/CT-P72 represents…
globenewswire.com Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives BURLINGTON, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq: ABP) (“Abpro” or the “Company”), a biotechnology company advancing next-generation antibody therapies, today…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
globenewswire.com Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager BURLINGTON, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Abpro Corporation (Nasdaq: ABP) (“Abpro”) and Celltrion, Inc. (“Celltrion”) today announced that they will present new preclinical data for…
globenewswire.com Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025 Achieved ~60% reduction in operating costs through a focused cost optimization plan DiversImmune® platform positioned to unlock additional pipeline value Reverse stock split supports Nasdaq…
defenseworld.net Abpro Holdings Inc. (NASDAQ:ABP) Sees Large Decrease in Short Interest Abpro Holdings Inc. (NASDAQ: ABP - Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket 
globenewswire.com Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of…
globenewswire.com Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and…
globenewswire.com Abpro Statement on the Departure of Former CEO Ian Chan WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and…